Latest Biotechnology, Pharmaceutical and Healthcare News from Colorado BioScience

02:07 EDT 19th July 2018 | BioPortfolio

Here are the most relevant search results for "Colorado BioScience" found in our extensive news archives from over 250 global news sources.

More Information about Colorado BioScience on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Colorado BioScience for you to read. Along with our medical data and news we also list Colorado BioScience Clinical Trials, which are updated daily. BioPortfolio also has a large database of Colorado BioScience Companies for you to search.

Showing News Articles 1–25 of 68 from Colorado BioScience

Monday 16th July 2018

Colorado BioScience Association Announces Departure of President & CEO, April Giles

Board of Directors to Begin National Search for Replacement DENVER – Colorado BioScience Association (CBSA) announces the departure of longtime President & CEO April Giles. She served CBSA for more than 12 years, providing operational leadership before assuming the President & CEO role in 2012, and will stay with CBSA until August 30. Scott Larson, Chairman of the CBSA Board of Direc...

Friday 13th July 2018

Weekly Policy Update: Medical Device Tax Advocacy and the CACI Legislative Candidate Interviews

CBSA continues to advocate for a full repeal of the Medical device tax in standalone legislation. A permanent repeal of the tax remains a top priority for CBSA and Colorado's medtech innovators. While we are appreciative for temporary relief through the two-suspension as part of the Continuing Resolution to fund the federal government, the suspension is set to expire on December 31, 2019.&...

Friday 6th July 2018

Weekly Policy Update: Meeting with Congresswoman Degette

This week Colorado BioScience Association along with AdvaMed, our Board Chair Scott Larson at Terumo BCT, Zimmer Biomet and ResMed met with Congresswoman DeGette. The meeting offered a great opportunity to talk about the importance of our industry and the exciting innovations taking place, as well as barriers presenting current challenges. As a senior member of the House Energy &...

Thursday 28th June 2018

Weekly Policy Update: Primary Elections, Congratulating Sen. Gardner, and Drug Pricing

2018 COLORADO PRIMARY ELECTION With the anticipated Colorado Primary Election this week, we learned the long-awaited results of who would be our top two democratic and republican candidates for Governor. This was a crowded race with the Democratic party candidate Jared Polis and the Republican Party candidate Walker Stapleton winning the nominations. For more information on the races for state se...

Wednesday 27th June 2018

Sapphire Technology Completes a Nationwide Distribution Agreement With Burkhart Dental Supply

Denver-based dental instrument company, Sapphire Technology, recently completed a nationwide distribution agreement with Burkhart Dental Supply (Tacoma, WA). Burkhart will soon market and sell Sapphire’s innovative and proprietary line of SGS® sapphire-tipped composite dental instruments. Established in 1888, Burkhart is one of the oldest and most established distributors of dental prod...

Monday 25th June 2018

New Office Location Helps Packaging Compliance Labs Accelerate Growth In Healthcare Packaging

Packaging Compliance Labs, a top medical device and pharmaceutical packaging engineering and validation firm, recently opened a new office in the heart of downtown Denver, Colorado, to accommodate rapid growth and leverage the area’s growing biotechnology industry. In addition to the headquarters in Grand Rapids, Michigan, the new office space grows PCL’s geographic footprint and supports...

Thursday 21st June 2018

Weekly Policy Update: FDA Releases Important Guidances

The FDA recently announced the release of an important guidances, “Drug and Device Manufacturer Communications With Payors, Formulary Committees, and Similar Entities–Questions and Answers,” and “Medical Product Communications That Are Consistent With the FDA-Required Labeling”. The first guidance answers common questions about companies’ communications to payors, including...

Friday 15th June 2018

Weekly Policy Update: Drug Pricing News

This week HHS Secretary Alex Azar appeared in front of the Senate Health, Education, Labor and Pensions Committee for a hearing on drug pricing. Secretary Azar’s prepared testimony in large part summarized President Trump’s blue print. For more information on the blueprint click here and to view the full hearing click h

Friday 8th June 2018

Weekly Policy Update: BIO International Convention

This week CBSA President and CEO April Giles and Vice President Jennifer Jones returned from the 2018 BIO International Convention in Boston, Massachusetts. This annual trip is a great opportunity to meet with CBSA member companies, industry partners, and other bioscience supporters. The convention also provides a venue where we can learn directly from industry leaders and share policy less...

Tuesday 5th June 2018

National Bioscience Industry Report Shows $2T Economic Impact, Accelerated Venture Capital Investment & Job Growth

A study released today at the BIO International Convention shows that the U.S. bioscience industry has reached $2 trillion in annual economic impact while maintaining accelerated venture capital investment and job growth numbers. Among U.S. technology sectors, the bioscience industry has held a leading position as an economic driver and job generator. The report, Investment, Innovation and...

Friday 1st June 2018

Weekly Policy Update: BIO International Convention and Voter Registration

POLICY UPDATES Yesterday the May Focus newsletter was published for a more detailed look at policy, and other issues, please read Jennifer’s monthly policy update in May’s Focus newsletter. 2018 BIO INTERNATIONAL CONVENTION On Saturday, Colorado BioScience Association President and CEO April Giles and Vice President Jennifer Jones depart for Boston, MA for the annual the 2018 BIO Interna...

Friday 25th May 2018

Weekly Policy Update: The Colorado Experience, Tariff Advocacy, and FDA Funding News

COLORADO EXPERIENCE – BOULDER This week Jennifer Jones, Vice President of the Colorado BioScience Association, participated in the Denver Metro Chamber Leadership Foundation’s Colorado Experience two-day trip with CO business and civic leaders trip to Boulder, CO. Participants learned about collaboration and entrepreneurism; then toured BIO Frontiers, Google, Innovation Center of St. V...

Friday 18th May 2018

Weekly Policy Update: A Quick Review of President Trump’s Prescription Medication Plan

Last Friday President Trump unveiled his administration’s plan to help make prescription drugs more affordable for patients. The blueprint called “American Patients First" builds on the president's 2019 budget proposal. After reviewing the policies listed in the blueprint and talking with our national partners we believe that some of the proposals could ultimately make medicines m...

Tuesday 15th May 2018

Just-Released Economic Data Finds Improving Education in Colorado Would Generate Billions for the Economy

New statewide polling shows education is a top tier issue for Colorado voters and employers, alignment on improvement strategies May 15, 2018 – Denver – If Colorado schools were the best in the nation, the state and its economy would receive a multi-billion-dollar boost. That’s the conclusion of a new study commissioned by Colorado Succeeds, Common Sense Policy Roundtable, the Denver Busin...

Friday 11th May 2018

Weekly Policy Update: The Close of the Second Regular Session and Unveiling Federal Drug Price Policies

120 Days... Second Regular Session of the 71st General Assembly is Over After 120 days, the Second Regular Session of the 71st session of the General Assembly ended on May 9, 2018. The successful passage of HB18-1135 - Extend Advanced Industry Export Acceleration Program sponsored by Reps. Tracy Kraft Tharp (D-Arvada) and Jim Wilson (R-Salida) and Sen. Jack Tate (R- Arapahoe) de...

Tuesday 8th May 2018

Coming Together as a Community

Collaborating on True Transparency to Benefit Patients Our state’s bioscience innovators work to create wearable devices to help make us healthier, develop drugs that could save a loved one from cancer, and identify disease-causing viruses and bacteria in food and water before they can make people sick. The people in our industry work with an inventive spirit to improve quality of life for...

Monday 7th May 2018

Gates Biomanufacturing Facility readies first shipment of clinical trial cancer treatments

Groundbreaking moment represents years of planning, training and biomedical expertise The Gates Biomanufacturing Facility at the University of Colorado Anschutz Medical Campus has passed an important landmark in manufacturing its first clinical trial-grade product for direct infusion into patients. The groundbreaking effort by the facility represents the culmination of several years of plannin...

Friday 4th May 2018

Weekly Policy Update: Industry Defeats Harmful Transparency Measures at the Capitol

CBSA had a busy legislative session advocating on behalf the industry against transparency measures that stood to stifle bioscience innovation in Colorado and failed to provide the relief patients need next time they pick up a prescription or schedule a procedure. On behalf of the Colorado BioScience Association, our members, and the bioscience industry, we thank the Colorado General A...

Monday 30th April 2018

Making a Difference for Patients

Meet the Colorado Leaders Developing Breakthrough Cures and Treatments Colorado’s researchers, innovators and entrepreneurs work to develop breakthroughs start locally and impact globally. Our sector’s creativity, collaboration and risk-taking spirit reflect our state’s values. More than 720 bioscience companies call Colorado home, and employ more than 30,000 Coloradans. We profile fou...

Friday 27th April 2018

Weekly Policy Update: HB-1358 Dies in Committee and Ongoing Transparency Advocacy

Advocating at the Capitol Today, April Giles, CBSA president & CEO testified in the House Health, Insurance, & Environment committee in opposition to HB18-1358 - Health Care Charges Billing Required Disclosures. The billed died in committee with a vote of 12 – 1. The bill would have required health insurance carriers to disclose “prescription drug prices” on a website, which includes...

Friday 20th April 2018

Weekly Policy Update: Action on Two Bills and Advocacy in DC

UNDER THE GOLD DOME This week, HB18-1135: Extend Advanced Industry Export Acceleration Program passed the Colorado House of Representatives and next week it moves to the Senate. This bill extends the advanced industries export acceleration program to businesses looking to expand and grow their business in international markets. It is an important top proactive bill that CBSA supports for ...

Prescription Drugs: Just the Facts

As the Colorado State Legislature considers House Bill 18-1260, Drug Price Transparency, a lot of claims and opinions are circulating in our state about the drivers of health care costs. Prescription drugmakers are a familiar target for those looking to place blame on rising out-of-pocket costs to patients. However, the facts demonstrate otherwise. Let’s break down some of the most com...

Monday 16th April 2018

Driving Down Drug Costs

Three Solutions to Help Patients and Support Innovators Current proposals under consideration at the Colorado State Legislature propose a simple fix for a complex issue. We agree, patients and their families need access to affordable medicines and health care. However, we believe patients need innovators and policymakers at the federal and state level to and address our health care system...

Friday 13th April 2018

Weekly Policy Update: CBSA Takes Positions on Additional Bills, Transparency News, and China Tariffs

UNDER THE DOME The Colorado BioScience Association took formal positions on three bills this week. With 18 working days left of session we continue to evaluate and make recommendations on legislation being introduced. Outlined below are details on four bills on which CBSA recently took a position. Please connect with us if you'd like to weigh in. CBSA SUPPORTS HB18-1284 - Disclosure of Pr...

Friday 6th April 2018

Weekly Policy Update: CO House Votes on Prescription Drug Price Transparency Bill Monday!

Colorado House Votes next week on Prescription Drug Price Transparency Bill (HB18-1260) CBSA continues to advocate against House Bill 1260, Prescription Drug Price Transparency. The bill could stifle bioscience innovation in Colorado and harm patients. Colorado Bioscience Association (CBSA) and BIO advocate for True Transparency to help patients understand the role of manufacturer

Quick Search


News Quicklinks